Treatment Hemorrhoidal Disease Using Sclerosing Foam Prepared with Medical Device

Introduction, Objectives, and/or Purpose: Hemorrhoidal disease is common in countries with a high standard of living. The endoscleromousse procedure of symptomatic hemorrhoids is very effective, painless and has no complications.
In this report we have analysed the results of the outpatient treatment of hemorroids using injection of sclerosing foam prepared with medical device.

Methods: We have treated 400 patients with variable degree (from I to IV degree) of hemorroidal disease and proctorrhagia from June 2022 to January 2023 using Medical Device to standardize the foam.
Each treatment was executed cranially to the pectinate line, where the sensitive innervation is absent.
The foam of Lauromacrogol 2% or 3% has been prepared with medical device, that allows to obtain a standardized sclerosing foam.
The quantity of injected medication per individual hemorroidal mass was never higher than 2 cc, with a maximum of 6 cc during each session.
Each session has an average duration of 8 minutes (range 6-12 minutes) with endoscopic tecnique, 4 minutes with anoscopic tecnique.
At the end of the procedure patients returned to their usual daily activity.

Results: We had organised a follow-up of three months, with controls and eventually repetition of procedures in the case of persistence of symptoms or incomplete sclerosis.
Each procedure was carried on every 20 days, without complications.
We carried out a total of 670 treatments on 400 patients.
At the end of the follow-up all the patients had improved quality of life, with resolution of bleeding and of anemia.

Conclusion(s): The use of medical device to prepare the sclerosing foam allows to obtain a standardized way to treat our patients. It also reduces collateral effects due to the variability in the preparation of sclerosing foam that depends to the operator.